Skip to main content

IMPACTO DE LA REPROGRAMACION METABOLICA DE LOS ASTROCITOS SOBRE LA FUNCION NEURONAL IN VIVO EN SALUD Y ENFERMEDAD

PID2019-105699RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Aberrant upregulation of glycolysis mediates CLN7 neuronal ceroid lipofuscinosis

  • García-Macia, Marina
  • López-Fabuel, Irene
  • Buondelmonte, Constantina
  • Burmistrova, Olga
  • Bonora, Nicoló
  • Morant Ferrando, Brenda
  • Alonso-Batán, Paula
  • Vicente-Gutiérrez, Carlos
  • Jimenez-Blasco, Daniel
  • Quintana-Cabrera, Ruben
  • Fernández, Emilio
  • McKay, Tristan R.
  • Storch, Stephan
  • Medina, Diego L.
  • Mole, Sara E
  • Fedichev, Peter O.
  • Almeida, Angeles
  • Bolaños, Juan P.
Resumen del trabajo presentado en el 43rd Annual Meeting of the Spanish Society of Biochemistry & Molecular Biology, celebrado en Barcelona, del 19 al 22 de julio de 2021, CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. CLN7/MFSD8 gene encodes a lysosomal membrane glycoprotein, but the biochemical processes affected by CLN7-loss of function are unexplored thus preventing development of potential treatments. Here, we found, in the Cln7∆ex2 mouse model of CLN7 disease, that failure in the autophagy-lysosomal pathway causes accumulation of structurally and bioenergetically impaired neuronal mi- tochondria. In vivo genetic approach revealed elevated mitochondrial reactive oxygen species (mROS) in Cln7∆ex2 neurons that mediates glycolysis activation and contributes to CLN7 pathogenesis. Mechanistically, mROS sustains a signaling cascade leading to protein stabilization of PFK- FB3, a glycolytic-promoting enzyme normally unstable in healthy neurons. Pharmacological inhibition of PFKFB3 in Cln7∆ex2 mouse brain in vivo and in CLN7 patients-derived cells rectified key disease hallmarks. Thus, aberrant upregulation of neuronal glycolysis contributes to CLN7 patho-genesis and targeting PFKFB3 may alleviate this and other lysosomal storage diseases, This work was funded by Agencia Estatal de Investigación (PID2019-105699RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
  • Bolaños, Juan P.
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor dis- coordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Bio-medicina 2017 Fundación BBVA and Fundación Ramón Areces. A.A. is unded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (PI18/00265, RD16/0019/0018) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are fundedby the grant CSI151P20 from the Junta de Castilla y Leon., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Impact of fatty acids on astrocytic bioenergetics

  • Morant Ferrando, Brenda
  • García-Macia, Marina
  • Jimenez-Blasco, Daniel
  • Fernández, Emilio
  • Carmeliet, Peter
  • Almeida, Angeles
  • Bolaños, Juan P.
Resumen del trabajo presentado en el 43rd Annual Meeting of the Spanish Society of Biochemistry & Molecular Biology, celebrado en Barcelona, del 19 al 22 de julio de 2021, Brain fatty acids metabolism remains underexplored. Recent reports have suggested that astrocytes may utilize fatty acids (1). However, whether acetyl-CoA metabolic fate is the tricarboxylic acid (TCA) cycle to obtain energy, the biosynthesis of ketone bodies, or both metabolic pathways, have not been yet fully deciphered yet (2,3). Besides this, astrocytes contribute to neuronal energy metabolism by shuttling to neurons metabolic glucose-derived precursors, such as lactate (4). However, it is unknown whether neurons utilize astrocytic-generated ketone bodies as energy precursors to maintain neurotransmission (5,6). Here, we aimed to address this issue using a mouse genetic model unable to perform ß-oxidation, specifically in astrocytes.We used a carnitine palmitoyltransferase-1A (CPT1A) gene floxed mouse model to elaborate cortical astrocyte cultures (7). Then, we infected them with adeno-associated viruses (AAVs) that express Cre recombinase (CMV-Cre-GFP) or not (CMV-GFP) to obtain CPT1a-KO and WT astrocytes, respectively. To test whether astrocytes use fatty acids as a mitochondrial fuel, we treated CPT1a-KO and WT astrocytes with oleic acid (250 μM) for 24 hours and measured the rate of oxygen consumption (OCR) using the Seahorse technology. Our results show that oleic acid treatment increases basal respiration and ATP-linked oxygen consumption in WT, but not in CPT1a-KO astrocytes. These changes were not ascribed to possible changes in the mitochondrial population according to citrate synthase activity and TOMM20 expression levels. These results indicate that astrocytes can oxidize fatty acids to produce energy, although further studies need to be performed to decipher if astrocytes are able to synthesize ketone bodies. Ongoing work is being developed to validate these observations in vivo, This work was funded by Agencia Estatal de Investigación (PID2019-105699RB-I00).